Lv1
40 积分 2023-07-21 加入
Odronextamab, a human CD20×CD3 bispecific antibody in patients with CD20-positive B-cell malignancies (ELM-1): results from the relapsed or refractory non-Hodgkin lymphoma cohort in a single-arm, multicentre, phase 1 trial
8小时前
已完结
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
8小时前
已完结
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers
9小时前
已完结
Anti-GPRC5D CAR T-cell therapy as a salvage treatment in patients with progressive multiple myeloma after anti-BCMA CAR T-cell therapy: a single-centre, single-arm, phase 2 trial
9小时前
已完结
Targeting common disease pathomechanisms to treat amyotrophic lateral sclerosis
4个月前
已完结
Evaluation of NUN-004, a Novel Engineered Ephrin Antagonist, in Healthy Volunteers and Patients with Amyotrophic Lateral Sclerosis: A Phase I/Ib, Open-Label, Escalating Dose and Extended Access Study
4个月前
已完结
SBT-272 improves TDP-43 pathology in ALS upper motor neurons by modulating mitochondrial integrity, motility, and function
9个月前
已完结
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
1年前
已完结
Advances in Gene Therapy Approaches Targeting Neuro-inflammation in Neurodegenerative Diseases
1年前
已完结
RAG-17: A Novel siRNA Conjugate Demonstrating Efficacy in Late-Stage Treatment of SOD1G93AALS mice
1年前
已完结
皖公网安备34019202002308
